Kasanin, J. The acute schizoaffective psychoses. Am J Psychiatry
1933; 90: 97–126.
Marneros, A. Beyond the Kraepelinian dichotomy: acute and transient psychotic disorders and the necessity for clinical differentiation. Br J Psychiatry
2006; 189: 1–2.
Craddock, N, O'Donovan, MC, Owen, MJ. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull
2006; 32: 9–16.
Cardno, AG, Rijsdijk, FV, Sham, PC, Murray, RM, McGuffin, P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry
2002; 159: 539–45.
Laursen, TM, Labouriau, R, Licht, RW, Bertelsen, A, Munk-Olsen, T, Mortensen, TB. Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study. Arch Gen Psychiatry
2005; 62: 841–8.
Funke, B, Malhotra, AK, Finn, CT, Plocik, AM, Lake, SL, Lencz, T, et al. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct
2005; 1: 19.
Green, EK, Raybould, R, Macgregor, S, Gordon-Smith, K, Heron, J, Hyde, S, et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry
2005; 62: 642–8.
Williams, NM, Green, EK, Macgregor, S, Dwyer, S, Norton, N, Williams, H, et al. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry
2006; 63: 366–73.
Kendler, KS. Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry
2006; 163: 138–46.
Rattiner, LM, Davis, M, Ressler, KJ. Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learn Mem
2004; 11: 727–31.
Berton, O, McClung, CA, Dileone, RJ, Krishnan, V, Renthal, W, Russo, SJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science
2006; 311: 864–8.
Egan, MF, Kojima, M, Callicott, JH, Goldberg, TE, Kolachana, BS, Bertolino, A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell
2003; 112: 257–69.
Sklar, P, Gabriel, SB, McInnis, MG, Bennett, P, Lim, YM, Tsan, G, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry
2002; 7: 579–93.
Neves-Pereira, M, Mundo, E, Muglia, P, King, N, Macciardi, F, Kennedy, JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder. Evidence from a family-based association study. Am J Hum Genet
2002; 71: 651–5.
Geller, B, Badner, JA, Tillman, R, Christian, SL, Bolhofner, K, Cook, EH Jr. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry
2004; 161: 1698–700.
Müller, DJ, de Luca, V, Sicard, T, King, N, Strauss, J, Kennedy, JL. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry
2006; 189: 317–23.
Strauss, J, Barr, CL, George, CJ, Devlin, B, Vetro, A, Kiss, E, et al. Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry
2005; 10: 861–7.
Schumacher, J, Jamra, RA, Becker, T, Ohlraun, S, Klopp, N, Binder, EB, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry
2005; 58: 307–14.
Neves-Pereira, M, Cheung, JK, Pasdar, A, Zhang, F, Breen, G, Yates, P, et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry
2005; 10: 208–12.
Duman, RS, Monteggia, LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry
2006; 59: 1116–27.
First, MB, Spitzer, R, Williams, JBW, Gibbon, M. Structured Clinical Interview for Axis I DSM–IV Disorders – Patient Edition (SCIDI/P, Version 2.0). Biometric Research Department, 1998.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, (4th edn) (DSM–IV). APA, 1994.
First, MB, Spitzer, R, Williams, JBW, Gibbon, M. Structured Clinical Interview for Axis I DSM–IV Disorders – Non-Patient Edition (SCID–NP, Version 2.0). Biometric Research Department, 1998.
Barrett, JC, Fry, B, Maller, J, Daly, MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics
2005; 21: 263–5.
Gabriel, SB, Schaffner, SF, Nguyen, H, Moore, JM, Roy, J, Blumenstiel, B, et al. The structure of haplotype blocks in the human genome. Science
2002; 296: 2225–9.
Stephens, M, Donnelly, P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet
2003; 73: 1162–9.
Van Os, J, Gilvarry, C, Bale, R, Van Horn, E, Tattan, T, White, I, et al. A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychol Med
1999; 29: 595–606.
Hodgkinson, CA, Goldman, D, Jaeger, J, Persaud, S, Kane, JM, Lipsky, RH, et al. Disrupted in schizophrenia1(DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet
2004; 75: 862–72.
Hamshere, ML, Bennett, P, Williams, N, Segurado, R, Cardno, A, Norton, N, et al. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry
2005; 62: 1081–8.
Kanazawa, T, Glatt, SJ, Kia-Keating, B, Yoneda, H, Tsuang, MT. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet
2007; 17: 165–70.
Lohoff, FW, Sander, T, Ferraro, TN, Dahl, JP, Gallinat, J, Berrettini, WH. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet
2005; 139: 51–3.
Green, EK, Raybould, R, MacGregor, S, Hyde, S, Young, AH, O'Donovan, MC, et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder. Case–control study of over 3000 individuals from the UK. Br J Psychiatry
2006; 188: 21–5.
Hwang, JP, Tsai, SJ, Hong, CJ, Yang, CH, Lirng, JF, Yang, YM. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging
2006; 27: 1834–7.
Borroni, B, Archetti, S, Costanzi, C, Grassi, M, Ferrari, M, Radeghieri, A, et al. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol Aging
Lencz, T, Lambert, C, DeRosse, P, Burdick, KE, Morgan, TV, Kane, JM, et al. Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. Proc Natl Acad Sci USA
2007; 104: 19942–7.
Iles, MM. What can genome-wide association studies tell us about the genetics of common disease?
2008; 4: e33.
Meyer-Lindenberg, A, Straub, RE, Lipska, BK, Verchinski, BA, Goldberg, T, Callicott, JH, et al. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest
2007; 117: 672–82.
Szeszko, PR, Lipsky, R, Mentschel, C, Robinson, D, Gunduz-Bruce, H, Sevy, S, et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry
2005; 10: 631–6.
Zhao, X, Tang, R, Gao, B, Shi, Y, Zhou, J, Guo, S, et al. Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet
2007; 80: 12–8.
Ober, C, Tan, Z, Sun, Y, Possick, JD, Pan, L, Nicolae, R, et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med
2008; 358: 1682–91.
Brzustowicz, L. Size matters: the unexpected challenge of detecting linkage in large cohorts. Am J Psychiatry
2007; 164: 192–4.
Lencz, T, Morgan, TV, Athanasiou, M, Dain, B, Reed, CR, Kane, JM, et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry
2007; 12: 572–80.
Tang, H, Quertermous, T, Rodriguez, B, Kardia, SL, Zhu, X, Brown, A, et al. Genetic structure, self-identified race/ethnicity, and confounding in casecontrol association studies. Am J Hum Genet
2005; 76: 268–75.
Woo, NH, Teng, HK, Siao, CJ, Chiaruttini, C, Pang, PT, Milner, TA, et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci
2005; 8: 1069–77.
Agassandian, K, Gedney, M, Cassell, MD. Neurotrophic factors in the central nucleus of amygdala may be organized to provide substrates for associative learning. Brain Res
2006; 1076: 78–86.
Chen, PS, Peng, GS, Li, G, Yang, S, Wu, X, Wang, CC, et al. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry
2006; 11: 1116–25.
Choi, MJA, Kang, RH, Lim, SW, Oh, KS, Lee, MS. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res
2006; 1118: 176–82.
Chen, L, Lawlor, DA, Lewis, SJ, Yuan, W, Abdollahi, MR, Timpson, NJ, et al. Genetic association study of BDNF in depression. Finding from two cohort studies and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet
2008; 147B: 814–21.
Deeb, SS, Fajas, L, Nemoto, M, Pihlajamäki, J, Mykkänen, L, Kuusisto, J, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet
1998; 20: 284–7.
Zeggini, E, Scott, LJ, Saxena, R, Voight, BF, Marchini, JL, Hu, T, et al. Metaanalysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet
2008; 40: 638–45.